Thrombopoietic agent
Thrombopoietic agent
A Thrombopoietic agent (pronunciation: throm-bo-po-et-ic agent) is a type of drug or substance that stimulates the production of platelets in the blood. These agents are often used in the treatment of conditions that cause low platelet counts, such as chemotherapy, radiation therapy, and certain blood disorders.
Etymology
The term "Thrombopoietic agent" is derived from the Greek words "thrombos" meaning clot, "poiesis" meaning production, and "agent" referring to a substance or drug that brings about a certain effect.
Types of Thrombopoietic agents
There are several types of Thrombopoietic agents, including:
- Eltrombopag - A drug used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) and chronic hepatitis C infection.
- Romiplostim - A drug used to stimulate platelet production in patients with chronic ITP.
- Oprelvekin - A drug used to prevent severe thrombocytopenia and to reduce the need for platelet transfusions following myelosuppressive chemotherapy in patients at high risk of developing severe thrombocytopenia.
Related Terms
- Thrombocytopenia - A condition characterized by abnormally low levels of platelets in the blood.
- Thrombopoiesis - The process of platelet production in the body.
- Thrombopoietin - A hormone produced by the liver and kidneys that promotes the production of platelets by the bone marrow.
See Also
External links
- Medical encyclopedia article on Thrombopoietic agent
- Wikipedia's article - Thrombopoietic agent
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski